title: Flunarizine- and topiramate-associated depression responsive to mirtazapine.
authors.affiliation: Department of Psychiatry, Langley Porter Psychiatric Institute, Consultation-Liaison Service, University of California, San Francisco Medical Center, San Francisco, CA.
authors.forename: James A
authors.initials: JA
authors.lastname: Bourgeois
authors.forename: Ana
authors.initials: A
authors.lastname: Hategan
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000139:chemically induced / Q000188:drug therapy*; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005444:Flunarizine / Q000009:adverse effects*; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D020325:Migraine with Aura / Q000188:drug therapy*; D000078785:Mirtazapine; D000077236:Topiramate
chemical_list: D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D000077236:Topiramate; D008803:Mianserin; D005632:Fructose; D000078785:Mirtazapine; D005444:Flunarizine